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Precise information about varicella-zoster virus (VZV) infection in first-trimester fetuses remains sketchy.
After varicella infection was diagnosed in a woman, her 12-week-old fetus was aborted and was investigated,
by histological examination, virus culturing, polymerase chain reaction, in situ hybridization (ISH), and im-
munohistochemistry (IHC), for the presence of VZV infection. Only the results of the histological examination
suggested the presence of a-herpesvirus infection, in the gastrointestinal tract and liver; results of ISH were
positive for VZV, and results of IHC staining were positive for intermediate early protein 63 (IE63) but negative
for glycoprotein E (gE), in the dorsal root ganglia (DRG), meninges, gastrointestinal tract, pancreas, smooth
muscle, liver, and placental trophoblast, indicating the presence of a nonproductive, latency-like VZV infection.
Only the gastrointestinal tract and liver exhibited simultaneous staining for IE63 and gE, a result suggesting
that active replication of VZV was present. In conclusion, widespread nonproductive VZV infection in the
absence of histological clues is an early event in VZV infection in fetuses. The observed gene-expression pattern
in most tissues resembles that of latent VZV infection in DRG. Latency-like infection in nonneural cell types
may potentially reactivate, leading to multifocal necrosis, fibrosis, and dystrophic calcifications, as observed
in advanced congenital varicella syndrome.
Primary varicella-zoster virus (VZV) infection during
the first 2 trimesters of pregnancy may result in con-
genital varicella syndrome (CVS); the highest risk is
∼2%, during weeks 13–20 [1]. CVS may either be lim-
ited to a single organ, such as the eye [2] or the skin
[3], or involve the skin, the neural system, the gastro-
intestinal tract, the urogenital tract, the eyes, the mus-
cles, and other organs. Multiple lesions and malfor-
mations frequently lead to fetal death [4, 5]. VZV DNA,
detected by polymerase chain reaction (PCR), as well
as VZV antigens, detected by immunohistochemistry
(IHC), have been identified in various organs, including
the lung, liver, skin, brain, and adrenal glands [6–10].
The association between certain congenital anomalies
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and virological and serological evidence of prenatal
VZV infection has proved that maternal varicella in-
fection causes CVS. But information on the distribution
of VZV DNA and gene products in the tissues of first-
trimester fetuses early in the course of fetal infection
is lacking. Therefore, we used a combination of his-
tological examination, PCR, in situ hybridization (ISH),
and IHC to study VZV infection in a 12-week-old fetus.
PATIENT, MATERIALS, AND METHODS
The mother provided informed consent to publish in-
formation about her and her fetus.
Histology. Routine histological examination of sam-
ples of the placenta and fetal tissues was performed on
formalin-fixed, paraffin-embedded hematoxylin-eosin–
stained sections. Fetal tissue samples were examined for
evidence of a-herpesvirus infection, such as multinucle-
ated giant cells and intranuclear inclusions; the placenta
was examined for evidence of VZV infection, such as
multifocal chronic villitis with multinucleated giant cells.
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Table 1. Primer/probe system for detection of varicella-zoster virus (VZV) DNA.







NOTE. (A), acceptor dye LC-red 640 coupled to the 5′ end of the VZV probe; (d), downstream
primer; (D), donor dye fluorescein coupled to the 3′ end of the VZV probe; gE, glycoprotein E; (u),
upstream primer.
Serology and virus culturing. Maternal serum was tested
for VZV-specific IgM and IgG antibodies, by EIA (Enzygnost;
Dade Behring) performed according to instructions supplied
by the manufacturer of the kit that was used. RF-Absorbent
(Dade Behring) was used to remove IgM rheumatoid factors
from the serum before the sample was tested for the presence
of IgM antibodies. In addition, an in-house IgG-avidity assay
was performed; avidity was determined by a dissociation tech-
nique using the avidity reagent for the Enzygnost EIA. For virus
culturing, a fetal tissue sample was inoculated into permissive
human embryonal lung fibroblasts that were subcultured after
2 weeks. All cultures were observed for 4 weeks, to determine
whether cytopathogenic effects were present.
Extraction of DNA for PCR. Before DNA was extracted
from them, tissue samples were pretreated with proteinase K
(0.5 mg/mL, in 10 mmol/L Tris-HCL [pH 7.6], 10 mmol/L
NaCl, and 2 mmol/L EDTA) for 2 h at 37C. Extraction of
DNA from the liquefied tissue was performed on a MagNA
Pure LC automated instrument, by use of a MagNA Pure LC
Total Nucleic Acid isolation kit (Roche Diagnostics). The ex-
tracted DNA was thus highly purified and ready for use in PCR.
Amplification of VZV DNA by real-time PCR. VZV DNA
was detected by use of a real-time PCR protocol and a Light-
Cycler (LC) instrument. Amplification primers were chosen to
amplify a 203-bp fragment of the gene for viral glycoprotein
E (gE). The PCR master mix was based on a ready-to-use kit
(LC FastStart DNA Master Hyb Probes; Roche Diagnostics)
containing FastStart Taq polymerase and 2′-deoxynucleoside
5′-triphosphates mix. The mix was supplemented with MgCl2
(4 mmol/L); uracil-N-glycosylase (UNG) (1 U); an upstream
primer designated “VZV-gE(u)” and a downstream primer des-
ignated “VZV-gE(d)” (0.5 mmol/L each); and both a probe fluo-
rescently labeled with acceptor dye LC-Red 640 (Roche Diag-
nostics) at the 5′ end of VZV and designated “VZV-(A),” and a
probe fluorescently labeled with the donor dye fluorescein cou-
pled to the 3′ end of VZV and designated “VZV-(D)” (0.1 and
0.2 mmol/L, respectively). After 15 mL of this mixture was pipetted
into LC capillaries, 5 mL of the crude neucleic-acid preparation
was added and the PCR run was started. For PCR, the following
temperature profile was used: a 5-min step at room temperature,
to enable UNG activity, and a 10-min step at 94C, to inactivate
UNG and to activate the FastStart Taq DNA Polymerase, before
cycling. Cycling comprised 10 cycles of the following: denatur-
ation (5 s at 95C), annealing (15 s at 65C and with a 1C/cycle
decrease from 65C to 55C), and extension (25 s at 72C),
followed by 45 cycles of denaturation (10 s at 95C), annealing
(20 s at 55C), and extension (15 s at 72C). Sequences of primers
and probes are given in table 1.
Antibodies and nucleic-acid probes. The characteristics of
(1) the polyclonal antibody (Pab) against IE63; (2) the mono-
clonal antibody (Mab) against IE63; (3) VL8, the antibody against
gE; (4) antibody against 1U1 (Argene Biosoft); (5) the antibodies
against IE63 that were used to detect various VZV-gene products;
(6) the Pabs against herpes simplex virus (HSV)–1 and HSV-2;
and (7) the DNA probes used in the ISH assays for VZV, HSV-
1, and HSV-2 have been published elsewhere [11].
IHC. IHC was performed according to previously pub-
lished protocols [11]. In short, primary-antibody incubation
was performed by use of dilutions and incubation times that
have been published elsewhere [11]. Subsequently, the slides
were washed in Tris-buffered saline (TBS) and incubated for
30 min with the secondary antibodies (biotinylated swine anti-
rabbit antibody diluted 1:300 and biotinylated rabbit anti-
mouse antibody diluted 1:400; Dakopatts). Slides were rinsed
in TBS and were covered by use of a polymer-based revelation
system (EnVision; Dakopatts). After the slides had been rinsed
in TBS, Fast Red (Dakopatts) was used as chromogen substrate
for 5 min. The last steps consisted of counterstaining with
Mayer’s hemalun and mounting in Glycergel mounting me-
dium (Dakopatts).
ISH. ISH was performed as described elsewhere for the
EcoRI-(A) restriction-endonuclease fragment (in which acceptor
dye LC-Red 640 is coupled to the 5′ end of EcoRI) [11]. The
biotinylated probes for VZV, HSV-1, and HSV-2 [11] were used
as follows: 5-mm sections were deparaffinized and then were
treated, for 15 min at 37C, with a solution containing proteinase
K (10 mg/mL; Boehringer-Mannheim). The sections then were
incubated, for 30 min at 37C, in 10 mL of the hybridization
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Figure 1. Detection of varicella-zoster virus (VZV) DNA in fetal tissue. Primers and probes were designed to enable fluorescence-resonance-energy
transfer. The accumulating fluorescence (vertical axis), which is obtained by amplification of the 203-bp fragment of the gene for viral glycoprotein E,
is acquired once per cycle (horizontal axis) and is displayed as a separate graphed line for each sample type. Although the positive control (),
containing an intermediate number of copies of VZV DNA, crosses the baseline fluorescence value at cycle 24, the negative control () remains at
baseline values throughout the entire polymerase chain reaction. The remaining graphed line (i.e., that which does not include symbols), which is
obtained by amplification of DNA extracted from fetal tissue, intersects the baseline fluorescence values, which already are apparent at cycles 10-
12, a result indicating the presence of a high viral burden.
mixture containing 50% deionized formamid, 10% dextran sul-
fate, 15% 20  SSC (3 mol/L chloride, 0.3 mol/L citrate), and
25% distilled water. Subsequently, the probe mixtures were in-
cubated (1 mg/mL each of biotinylated VZV, HSV-1, and HSV-
2 nucleic-acid fragments, in 50% deionized formamid, 10% dex-
tran sulfate, and 15% 20  SSC). After denaturation for 3 min
at 90C, the hybridization reaction continued for 60 min at 37C.
Slides were rinsed in TBS and were washed in a buffer (2 
SSC) for 30 min at 37C. Alkalin phosphatase–coupled avidin
biotin was applied for 30 min, and nitroblue tetrazolium and
bromochloroindolylphosphate (Dakopatts) then were applied for
60 min. Sections were counterstained with Fast Red and were
mounted in Glycergel.
Controls. Control specimens consisted of normal healthy
skin and fetal tissue resulting from abortion. Positive control
specimens included vesicular HSV and VZV skin infections
from previous studies [11]; in IHC, ISH, and PCR, either the
omission of primary-antibody incubation, secondary-antibody
incubation alone, and/or probe/primer incubation served as a
negative control.
RESULTS
Case history and laboratory findings. A 31-year-old, healthy,
gravida 1, para 0 woman started her last menstrual period on
27 February 2003. On 8 May 2003, she presented with the
classic clinical symptoms of chickenpox. In a Stuttgart labo-
ratory (Labor Enders, Institut fu¨r Virologie, Infektiologie und
Epidemiologie, Stuttgart, Germany), pimary maternal VZV in-
fection was serologically confirmed, by both an elevated IgM
titer (IgM index, 8.3; cutoff index, 1.0) and a low IgG-avidity
index (10.8%). At both 10 weeks 4 days gestation and 11 weeks
1 day gestation, fetal ultrasound showed no abnormalities; but
fetal death was diagnosed at 12 weeks gestation, and the woman
was admitted to a hospital in Hagen (Department of Obstetrics
and Gynecology, Allgemeines Krankenhaus, Hagen, Germany),
so that labor, induced by prostaglandin, and subsequent cu-
rettage could be performed. Fetal/placental tissue specimens
were analyzed by conventional histopathological examination
(Department of Pathology, Allgemeines Krankenhaus, Hagen,
Germany). The initial routine histological examination of these
specimens revealed no signs that would suggest that a-her-
pesvirus infection was present. At the same time, some of the
tissue specimens were send to the Stuttgart laboratory, for virus
culturing and VZV PCR; no VZV was isolated, but the results
of real-time PCR of fetal products were found, on the basis of
a semiquantitative estimation, to be highly positive for VZV
DNA (figure 1). To rule out the possibility that contamination
by VZV DNA from maternal tissues or fluids could have oc-
curred during curettage, formalin-fixed sections of tissue sam-
ples from the placenta and from the fetus were send to a Lie`ge
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Figure 2. 1, Positive results of immunostaining for varicella-zoster virus (VZV) intermediate early protein 63 (IE63) in fetal dorsal root ganglia (red
signal [40]). 2, Positive results of immunostaining for VZV IE63 in a fetal dorsal root ganglion (red signal [100]). 3, Positive results of immuno-
histochemistry (IHC) staining for VZV IE63 in a fetal dorsal root ganglion (red signal [100]). 4, Positive results of IHC staining for VZV glycoprotein
E in the digestive tract (red signal [100]). 5, Positive results of in situ hybridization (ISH) staining for VZV in fetal liver (dark-blue nuclear signal
[indicated by arrows] [40]). 6, Positive results of ISH staining for VZV in a fetal dorsal root ganglion (dark-blue nuclear signal [indicated by arrows]
[100]).
laboratory (Department of Dermatopathology, University Hos-
pital Sart Tilman, Lie`ge, Belgium), for further investigation (by
use of ISH and IHC). When the histological slides were re-
viewed in the context of the positive VZV-PCR results, cytolytic
areas were observed both in tissue specimens from the liver
and in those from the gastrointestinal tract. Both the IE63 Pab
and the IE63 Mab showed a strong nuclear and cytoplasmic
IHC signal in the cells of various tissue samples (figure 2). The
antibodies against late (L) gE and L VZV showed prominent
membranous and weak cytoplasmic immunostaining. ISH gave
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Table 2. Varicella-zoster virus (VZV): comparison of histological results, immunohistochemistry (IHC)
results, and in situ hybridization (ISH) results.















Striated muscle   +  + 
Smooth muscle   +  + 
Pancreas   +  + 
Adrenal cortex   +  + 
Spinal cord   +  + 
Dorsal root ganglia   +  + 
Gastrointestinal tract + + +  + 
Liver + + +  + 
Placental trophoblast   +  + 
Villosities   +  + 
Control
VZV + + +  + 
HSV +   +  +
Normal healthy skin      
NOTE. (A), acceptor dye LC-Red 640 coupled to the 5′ end of EcoRI; Abs, antibodies; gE, glycoprotein E; HSV, herpes
simplex virus; IE, intermediate early; L, late; Mab, monoclonal antibody; Pab, polyclonal antibody; +, positive; , negative.
a Evidence of a-herpesvirus infection.
a positive nuclear signal in infected cells of the fetal and pla-
cental tissue samples. The histological, ISH, IHC, and control
data are summarized in table 2. For several major organs (fetal
brain, heart, lung, and spleen), tissue specimens could not be
retrieved from the available paraffin-embedded sections.
DISCUSSION
To our knowledge this is the first report that describes the
distribution of VZV DNA and gene products in placental and
fetal tissues at an early stage of fetal VZV infection. The pla-
cental trophoblast and the villosities did not exhibit the mi-
croscopic alterations typical of viral infection; however, ISH
showed evidence of VZV DNA in the placenta, and, in addition,
IE63 was identified by IHC. These results call for complemen-
tary viral identification in placental tissue samples when clini-
cal evidence of viral infection is present, even when histolog-
ical evidence of a-herpesviruse is absent. It is indeed possible
that a fetus could be aborted before such histological alterations
can be observed. A productive VZV infection is biologically
characterized by both (1) expression of the IE gene and the L
gene and (2) histologically recognizable cytopathic effects [11].
Latent-VZV–infection patterns in human DRG are linked to
the sole expression of IE-gene products—such as IE63, IE62,
and IE4—and of some E-gene products, as has been demon-
strated in rats [12] and humans [13]. In the present case, tissue
specimens from some organs (e.g., the gastrointestinal tract and
the liver) show cytopathic effects and are associated with pos-
itive results of ISH, as well as IE- and L-gene product expres-
sion, which suggests that active replication of VZV is present.
Other tissues exhibit VZV DNA associated with gene expression
restricted to some IE genes (table 2). This expression pattern
resembles the latent-gene–expression pattern in DRG, or it
could be viewed as a kind of abortive infection that has been
described by Lungu et al. [14]. Our findings demonstrate that
histopathological examination may underestimate the extent of
viral dissemination in a fetus. Furthermore, primary VZV in-
fection during pregnancy may result in fetal infection more
often than previously has been thought. That the number of
organs showing productive VZV infection (i.e., positive results
of immunostaining for IE63 and for gE) is far less than the
number of organs showing nonproductive VZV infection (i.e.,
positive results of immunostaining for IE63 but negative results
of immunostaining for gE) possibly explains the limited sen-
sitivity of VZV culturing [15].
On the basis of the clinical pattern of CVS, it has been
suggested that the pathogenic mechanisms depend on the initial
endogenous VZV reactivation in sensory ganglia of the pos-
terior roots of the spinal cord [16]. But several manifestations
(e.g., multifocal necrosis in parenchymatous organs and mul-
tiorgan distribution of dystrophic microcalcifications) of com-
plex CVS are suggestive of a nonsegmental distribution of VZV
infection. In the fetus examined in the present study, numerous
nonneural organs showed ISH signals positive for VZV that
were associated with IHC results showing strong expression of
IE63. This observation may support the concept of an early
disseminated infection of susceptible nonneural cells and local
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VZV reactivation with consecutive tissue damage, a concept
that has been proposed by others [17]. Early disseminated VZV
infection in the absence of an adequate immune response to
VZV has also been demonstrated in human adults [18]. Some
investigators have found evidence, based on the detection of
VZV DNA, of VZV persistence in nonneural fetal tissues [6,
8, 10]. Furthermore, an ongoing (120 weeks) active inflam-
mation around viral inclusions has been demonstrated in a
fetus with CVS [9]. It is not clear whether the presence of VZV
DNA and the expression of IE protein without the expression
of gE possibly lead to cellular damage. Chronic inflammation
may be similar to postzoster granulomatous reactions in which
only VZV gE is evidenced, suggesting a delayed hypersensitivity
reaction to persistent glycoproteins [19]. However, involvement
of this mechanism in varicella infection in the first-trimester
fetus in the present study is unlikely, both because IE63 but
not gE was predominantly expressed and because the fetal im-
mune system was immature. Whether a latent gene-expression
pattern might result in specific pathological changes in infected
cells remains to be elucidated.
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